Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms
Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form ...
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year
By Dennis Thompson HealthDay Reporter THURSDAY, Oct. 24, 2024 (HealthDay News) -- Expanding access to cutting-edge diabetes ...
Exclusive: Weight-loss drugs didn't curb health costs within two years, data show
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...
Weight-loss drugs didn't curb health costs within two years, data show
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
GLP-1 drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...
Futurism on MSN22h
The Diet Industry Is Reportedly in Total Meltdown Over GLP-1 Weight Loss Drugs
With weight loss injectables like Ozempic and Mounjaro taking the world by storm, the diet industry is seemingly being left ...
The Financial Express6h
Data shows weight-loss drugs didn’t curb health costs within two years: Report
Prime Therapeutics reviewed pharmacy and medical claims data for 3,046 people with commercial health plans that cover GLP-1 ...
HR Dive51m
Employees are asking about GLP-1 coverage. What should employers do?
For GLP-1 treatment in particular, employers “need to make sure the coverage is married with a patient engagement program, ...
Pulse2h
MHRA urges GPs to be alert to signs of GLP-1 agonist ‘misuse’
The medicines regulator has urged GPs to be alert to signs of ‘misuse’ of GLP-1 receptor agonists for weight loss, such as ...
Grays Harbor Daily News18h
TerraHealthRX Review: Convenient Access to Weight Loss Medications Like Ozempic, No Insurance Needed
Weight loss can be a challenging journey, especially when seeking effective and accessible solutions. The rise in popularity ...
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
The Economist18h
GLP-1s like Ozempic are among the most important drug breakthroughs ever
But in March semaglutide (a GLP-1 receptor agonist sold as Ozempic for diabetes and Wegovy for weight-loss) was approved in ...